S2 Part 1: Processing and minor processing

Published Date: 16 Feb 2023

Dr. Jacob Sands and Dr. Jared Weiss talk about subtypes. ongoing clinical trials; sustained sustained response to treatment; And it is possible to use the word "cure" to treat a small breast cancer.

Read Full News

Latest News

S3 Episode 2: Endometrial Cancer Research: The Past, Present, and Future

Drs Ursula A. Matulonis and David G. Mutch discuss past and present endometrial cancer research, including the Route 66 SPORE.

S3 Episode 1: Phase 3 Trial ADCs in Endometrial Cancer

Drs Ursula Matulonis and Brian Slomovitz discuss phase 3 trials of ADCs in endometrial cancer and what's to come in the field of endometrial cancer therapeutics.

Lithium Beyond Bipolar: A New Role in Brain Health

Could lithium be more than a mood stabilizer? Dr James Greenblatt examines its emerging role in brain resilience and cognitive health.

The Thyroid Cancer Dilemma: Doing More Isn’t Always Better

With rising thyroid cancer rates but stable mortality, clinicians must weigh the costs of overdiagnosis to ensure precision care over unnecessary intervention.

S1 Episode 2: Can Early Genetic Testing Change ATTR-CM Outcomes?

Drs Kevin Alexander and Joban Vaishnav explore when and how to use genetic testing in ATTR-CM, why distinguishing hereditary from wild-type disease matters, and what this means for patients' families.

S1 Episode 1: Rethinking Rhythm Control in ATTR-CM

Is rhythm control underused in ATTR-CM? Drs Kevin Alexander and Ronald Witteles make the case for rethinking how we manage arrhythmias in this disease.

Todays Updates

Do Anatomy Atlases Reflect Social Inequalities?

Historical anatomical illustrations reflect social inequality and may require an ethical context to guide their continued use in clinical education and surgical reference.

MRD-Guided Azacitidine May Delay Relapse in AML, MDS

New data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or AML who develop MRD positivity.

HER3 Antibody Drug Conjugate Shows Promise in NSCLC

Researchers examine overall response rates of a HER3-targeting antibody-drug conjugate in pretreated patients with non-small cell lung cancer.

Todays Updates

Do Anatomy Atlases Reflect Social Inequalities?

Historical anatomical illustrations reflect social inequality and may require an ethical context to guide their continued use in clinical education and surgical reference.

MRD-Guided Azacitidine May Delay Relapse in AML, MDS

New data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or AML who develop MRD positivity.

HER3 Antibody Drug Conjugate Shows Promise in NSCLC

Researchers examine overall response rates of a HER3-targeting antibody-drug conjugate in pretreated patients with non-small cell lung cancer.

Latest News

Drs Ursula A. Matulonis and David G. Mutch discuss past and present endometrial cancer research, including the Route 66 SPORE.

Drs Ursula Matulonis and Brian Slomovitz discuss phase 3 trials of ADCs in endometrial cancer and what's to come in the field of endometrial cancer therapeutics.

Could lithium be more than a mood stabilizer? Dr James Greenblatt examines its emerging role in brain resilience and cognitive health.

With rising thyroid cancer rates but stable mortality, clinicians must weigh the costs of overdiagnosis to ensure precision care over unnecessary intervention.

Drs Kevin Alexander and Joban Vaishnav explore when and how to use genetic testing in ATTR-CM, why distinguishing hereditary from wild-type disease matters, and what this means for patients' families.

Is rhythm control underused in ATTR-CM? Drs Kevin Alexander and Ronald Witteles make the case for rethinking how we manage arrhythmias in this disease.

News All Time

Rules for Thee, Not for Me: Neuroscience & Double Standards

With respect to the so-called ‘moral compass’, humans invariably judge others more harshly than they judge themselves.

ACC 2026: Anticipating New Data in Amyloid and ATTR-CM

Dr Kevin M. Alexander prepares for updates on amyloid research, real-world evidence, and imaging biomarkers.

EoE on the Rise: What Every Endoscopist Should Know

Dr David Johnson highlights the recommendations most likely to change how you endoscopically manage this increasingly prevalent disease.

What the 'Relax Your Tight End' Super Bowl Ad Got Wrong

PSA tests are never 'simple.' Dr Kenny Lin discusses how to move beyond overdiagnosis toward truly informed prostate cancer screening.

Staying the Course After EGFR Progression

Dr Mark Kris highlights a recent study on osimertinib in NSCLC and outlines the best approaches for treatment beyond progression.

AI in Medicine Desperately Needs Less Hype and More Honesty

A Yale School of Medicine professor argues that total transparency is the only way AI can become a trustworthy tool for physicians and patients.

When Patients Feel Unheard: The Communication Gap in Care

Dr Mark Lewis discusses a recent social-media post which led to a reflection on how physicians can actively listen to patients and facilitate shared decision making.

Gastric Cancer: Focused Screening, Better Outcomes

Early detection saves lives in gastric cancer, but in Western settings the key lies in risk stratification, Helicobacter pylori eradication, and high-quality endoscopy.

Tethered to Tech, Nurses Suffer Digital Compassion Fatigue

The explosion of telehealth, remote monitoring, and screen-based charting is leading to digital compassion fatigue for nurses.

When Saying Less Helps in Primary Care Consultations

According to experts, primary care physicians may improve listening and therapeutic relationships by deliberately using silence during consultations.

What Happened to the Prestige of Being a Doctor?

‘Back in the day’ butts heads with ‘medicine today.’ A candid look at why physicians may never have the authority, respect, and trust doctors enjoyed 50 years ago.

Just 1 in 8 Nurses Would Recommend the Profession

Only 12% of UK nurses would recommend their profession — despite most reporting job satisfaction — as harassment, discrimination, and workload pressures take a toll.

Why Med Students Think They’re Dying (When They’re Not)

Studying disease amid the stress of medical school can make every headache a tumor and every muscle twitch ALS. Welcome to ‘med school syndrome.’ Try not to panic.

When the Doctor Needs a Checkup

Researchers have documented a gradual decline in physicians’ cognitive abilities starting in their mid-sixties.

Preventing Burnout in Clinical Practice

Perfectionism, empathy, and blurred boundaries — together with workload, staff shortages, and constant connectivity — create a high risk for stress for clinicians.

Recommended News For You

Medical Journal March 28, 2023

FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor

Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic Cancer

Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study

In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.

An inhibitor of JAK1 exhibits "remarkable" activity in T-cell lymphoma.

Antitumor mRNA-based vaccines show potential against gastric cancer metastasis

Recommended Articles For You

Amivantamab Plus Chemotherapy Outperforms Standard Care in Post-Osimertinib NSCLC 

Building Bridges between Heart and Cancer Care: A Comprehensive Guide to Cardio-Oncology Clinics 

Unleashing the Power of Immune Triads: A Novel Approach to Cancer Immunotherapy 

Precision to Personalization: Expanding Genetic Testing and Counseling in Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Having a tattoo could increase your risk of developing lymphoma.

2.

The way that miR-377 inhibits cells that cause prostate cancer.

3.

Prostate cancer early detection system eliminates need for biopsy.

4.

FDA Authorizes Three Different Uses for Injectable Antibiotic.

5.

Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

1.

A Breakthrough in Multiple Myeloma: Darzalex Delays Disease Progression by 51%

2.

Everything You Need To Know About Splenic Infarction – Symptoms, Treatments, And Prevention

3.

Hematologic Toxicity of CDK4/6 Inhibitors in Breast Cancer: Meta-Analysis and Safety Data

4.

Effective Management Strategies for Sickle Cell Crisis: Insights from Medical Experts

5.

Everything You Need to Know About HTLV: A Comprehensive Guide 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

4.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

5.

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot